68222-59-3 Usage
Description
N-[(Benzyloxy)carbonyl]-3-methylvaline is a chemical compound that serves as a reactant in the synthesis of diazabicycloheptyl amino acid derivatives. These derivatives are known for their antagonistic properties towards the transient receptor potential channel TRPV4.
Uses
Used in Pharmaceutical Industry:
N-[(Benzyloxy)carbonyl]-3-methylvaline is used as a reactant for the preparation of diazabicycloheptyl amino acid derivatives, which act as TRPV4 antagonists. These antagonists are valuable in the development of therapeutic agents targeting the TRPV4 channel, which is implicated in various physiological and pathological processes, including pain sensation, inflammation, and certain cardiovascular and kidney diseases. By modulating the activity of the TRPV4 channel, these antagonists can potentially offer novel treatment options for a range of conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 68222-59-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,2,2 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 68222-59:
(7*6)+(6*8)+(5*2)+(4*2)+(3*2)+(2*5)+(1*9)=133
133 % 10 = 3
So 68222-59-3 is a valid CAS Registry Number.
68222-59-3Relevant articles and documents
PROCESS FOR PRODUCTION OF N-ALKOXYCARBONYL-tert-LEUCINES
-
Page/Page column 13, (2012/03/26)
A high quality N-alcoxycarbonyl-tert leucine can be efficiently and stably produced with an easy procedure by reacting tert-leucine with an N-alcoxycarbonylating agent in the presence of water, wherein the use amount of the N-alcoxycarbonylating agent is not less than 0.90 times by mole and not more than 1.00 times by mole relative to the tert-leucine, with maintaining the pH of the reaction mixture in the range of not less than 9 and not more than 13 using a basic agent. In addition, an N-alcoxycarbonyl-tert-leucine can be efficiently extracted from the basic aqueous solution thereof under a mild condition using a water-immiscible solvent by mixing a hydroxide. Furthermore, the two crystal forms of N-butoxycarbonyl-tert-leucine can be controlled by adjusting the water amount in crystallization step, and the compound can be stably produced in an industrial production.